Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)
60.79 x 2 61.22 x 1
Pre-market by (Cboe BZX)
61.07 +0.65 (+1.08%) 03/21/25 [NYSE]
60.79 x 2 61.22 x 1
Pre-market 61.00 -0.07 (-0.11%) 08:39 ET
Quote Overview for Mon, Mar 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
60.85
Day High
60.85
Open 60.85
Previous Close 61.07 61.07
Volume 13,934 13,934
Avg Vol 12,597,472 12,597,472
Stochastic %K 48.65% 48.65%
Weighted Alpha +21.11 +21.11
5-Day Change +0.86 (+1.43%) +0.86 (+1.43%)
52-Week Range 39.35 - 63.33 39.35 - 63.33
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 123,930,080
  • Shares Outstanding, K 2,029,312
  • Annual Sales, $ 48,300 M
  • Annual Income, $ -8,948 M
  • EBIT $ 493 M
  • EBITDA $ 10,093 M
  • 60-Month Beta 0.43
  • Price/Sales 2.54
  • Price/Cash Flow 10.26
  • Price/Book 7.48

Options Overview Details

View History
  • Implied Volatility 28.59% ( +1.78%)
  • Historical Volatility 26.65%
  • IV Percentile 69%
  • IV Rank 51.83%
  • IV High 36.85% on 07/11/24
  • IV Low 19.71% on 12/26/24
  • Put/Call Vol Ratio 0.39
  • Today's Volume 50,465
  • Volume Avg (30-Day) 32,766
  • Put/Call OI Ratio 0.80
  • Today's Open Interest 598,957
  • Open Int (30-Day) 557,495

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.55
  • Number of Estimates 10
  • High Estimate 1.71
  • Low Estimate 1.43
  • Prior Year -4.40
  • Growth Rate Est. (year over year) +135.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
56.96 +6.83%
on 02/27/25
Period Open: 57.88
63.33 -3.92%
on 03/11/25
+2.97 (+5.13%)
since 02/24/25
3-Month
53.54 +13.65%
on 02/18/25
Period Open: 57.76
63.33 -3.92%
on 03/11/25
+3.09 (+5.35%)
since 12/24/24
52-Week
39.35 +54.64%
on 07/05/24
Period Open: 51.93
63.33 -3.92%
on 03/11/25
+8.92 (+17.18%)
since 03/22/24

Most Recent Stories

More News
2 High-Yield Dividend Stocks That Are Bargain Buys Right Now

Healthcare is a defensive sector that is more resilient to economic downturns than most others. That's one of several reasons it is home to solid dividend stocks, including Pfizer (NYSE: PFE) and Bristol...

PFE : 26.18 (-0.39%)
BMY : 60.85 (-0.36%)
Bristol Myers Stock Gains 9.2% in a Month: Should You Buy Now or Wait?

Shares of Bristol Myers BMY have risen 9.2% in the past month compared with the medical biomedical and genetics industry’s growth of 5%.  The stock has also outperformed the industry and the sector...

MRK : 93.10 (-0.01%)
PFE : 26.18 (-0.39%)
BMY : 60.85 (-0.36%)
EC Approves Bristol Myers' Opdivo Plus Yervoy for First-Line HCC

Bristol Myers BMY announced that the European Commission (EC) has approved the blockbuster immuno-oncology drug Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment of adult patients...

BMRN : 71.24 (-0.50%)
GILD : 107.23 (+0.14%)
BMY : 60.85 (-0.36%)
Is Bristol-Myers Stock Outperforming the Dow?

As Bristol-Myers has outperformed the Dow recently, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

$DOWI : 41,985.35 (+0.08%)
AMGN : 317.03 (+0.31%)
BMY : 60.85 (-0.36%)
How Is Pfizer's Stock Performance Compared to Other Pharmaceuticals Stocks?

Pfizer has underperformed the pharmaceuticals industry over the past year, but analysts are moderately optimistic about the stock’s prospects.

IHE : 70.21 (-0.25%)
PFE : 26.18 (-0.39%)
BMY : 60.85 (-0.36%)
Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers

Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers

CORT : 59.99 (+2.27%)
SUPN : 32.15 (-0.53%)
MRK : 93.10 (-0.01%)
ZTS : 163.02 (-0.01%)
BMY : 60.85 (-0.36%)
Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb

Ongoing strategic partnership advances joint pipeline in neurodegeneration research

EVO : 3.60 (+2.56%)
BMY : 60.85 (-0.36%)
Is Merck Stock Underperforming the S&P 500?

Despite Merck’s recent underperformance relative to the S&P 500 Index, Wall Street analysts remain moderately optimistic about the stock’s prospects.

$SPX : 5,667.56 (+0.08%)
MRK : 93.10 (-0.01%)
BMY : 60.85 (-0.36%)
Bristol-Myers Squibb (BMY): Buy, Sell, or Hold Post Q4 Earnings?

Bristol-Myers Squibb (BMY): Buy, Sell, or Hold Post Q4 Earnings?

MSFT : 396.10 (+1.24%)
BMY : 60.85 (-0.36%)
Got $200? 2 Healthcare Stocks to Buy and Hold Forever

Healthcare is considered a defensive industry, since good medical care is needed regardless of economic or market conditions. Therefore many companies in this sector are somewhat insulated from the impact...

$SPX : 5,667.56 (+0.08%)
DXCM : 75.01 (+1.64%)
BMY : 60.85 (-0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers...

See More

Key Turning Points

3rd Resistance Point 63.16
2nd Resistance Point 62.25
1st Resistance Point 61.66
Last Price 60.85
1st Support Level 60.16
2nd Support Level 59.25
3rd Support Level 58.66

See More

52-Week High 63.33
Last Price 60.85
Fibonacci 61.8% 54.17
Fibonacci 50% 51.34
Fibonacci 38.2% 48.51
52-Week Low 39.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals